Unichem Laboratories Quarterly Results for Trading Insights
In Mar 2026, Unichem Laboratories (UNICHEMLAB) reported revenue ₹599 Cr and net profit ₹11 Cr — revenue +0.5% YoY. Also explore UNICHEMLAB share price charts to track price trends across different timeframes.
UNICHEMLAB Quarterly Results — Revenue, Profit & EPS Highlights
Unichem Laboratories latest quarter revenue, net profit, EPS and QoQ/YoY growth rates. For annual financials, live price and key ratios, visit UNICHEMLAB stock price BSE.
- Revenue of ₹599 Cr in Mar 2026 (-0.2% vs Sept 2025, +0.5% vs Mar 2025)
- Net Profit of ₹11 Cr in Mar 2026 (+191.7% vs Sept 2025, -79.2% vs Mar 2025)
- EBITDA of ₹59 Cr in Mar 2026 (+103.4% vs Sept 2025)
- Operating Margin of 6.0% in Mar 2026 (+5.0pp vs Sept 2025)
- Earnings Per Share of ₹1.55 in Mar 2026 (+191.7% vs Sept 2025)
Unichem Laboratories Quarterly Results — Revenue, EBITDA, Net Profit & EPS
UNICHEMLAB quarterly revenue, expenses, EBITDA, net profit, EPS and operating margin with QoQ and YoY comparison.
| Metric | Mar 2026 | Sept 2025 | Mar 2025 | Jun 2025 | Dec 2025 | QoQ | YoY |
|---|---|---|---|---|---|---|---|
| Revenue (₹ Cr) | 599 | 600 | 596 | 533 | 809 | -0.2% | 0.5% |
| Net Profit (₹ Cr) | 11 | -12 | 53 | -11 | 264 | - | - |
| EBITDA (₹ Cr) | 59 | 29 | 93 | 29 | 332 | - | - |
| EPS (₹) | 1.55 | -1.69 | 7.52 | -1.49 | 37.54 | - | - |
| Operating Margin (%) | 6.0% | 1.0% | 14.0% | 4.0% | 9.0% | - | - |
UNICHEMLAB Share Price Trend — 1-Year Movement Across Quarterly Results
Unichem Laboratories 1-year share price in ₹ overlaid with quarterly earnings dates — NSE/BSE closing prices. Compare with UNICHEMLAB fair value estimate to assess whether the stock is under or overvalued.
Revenue Trend (₹ Cr)
Net Profit Trend (₹ Cr)
Operating Margin Trend (%)
UNICHEMLAB vs Healthcare Peers — Quarterly Revenue, Profit & Market Cap
Unichem Laboratories latest quarter revenue and net profit vs Healthcare competitors — market cap, price and earnings comparison.
| Company Latest Quarter | Market Cap (₹ Cr) | Price (₹) | Revenue (₹ Cr) | Net Profit (₹ Cr) | Rev QoQ % | Rev YoY % | Profit Margin % | P/E Ratio |
|---|---|---|---|---|---|---|---|---|
|
Sun Pharmaceutical
Mar 2026 |
₹442,581.33 Cr | 1844.3 | 15,018 | 2,710 | +1.0% | +11.8% | 18.0% | 163.2 |
|
Divis Laboratories
Mar 2026 |
₹179,363.85 Cr | 6797.5 | 2,986 | 751 | +4.4% | +11.8% | 25.2% | 240.1 |
|
Torrent Pharmaceuti…
Mar 2026 |
₹153,579.77 Cr | 4537.8 | 4,111 | 364 | +27.7% | +42.2% | 8.9% | 394.2 |
|
Cipla
Mar 2026 |
₹114,559.46 Cr | 1418.2 | 6,612 | 543 | -14.3% | -4.0% | 8.2% | 206.4 |
|
Dr Reddys Laborator…
Mar 2026 |
₹110,089.41 Cr | 1319.0 | 7,996 | 221 | -12.5% | -11.5% | 2.8% | 497.7 |
All amounts in ₹ Crores